These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 23532357)

  • 1. Cutaneous Mycobacterium intracellulare infection in an immuno-competent person.
    Zhou L; Wang HS; Feng SY; Wang QL
    Acta Derm Venereol; 2013 Nov; 93(6):711-4. PubMed ID: 23532357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disseminated cutaneous infection caused by Mycobacterium colombiense.
    Gao W; Chen H; Jiang H; Wang Q; Tang M; Wang HS
    Acta Derm Venereol; 2014 Nov; 94(6):727-8. PubMed ID: 24573766
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of clarithromycin and ethambutol for Mycobacterium avium complex pulmonary disease. A preliminary study.
    Miwa S; Shirai M; Toyoshima M; Shirai T; Yasuda K; Yokomura K; Yamada T; Masuda M; Inui N; Chida K; Suda T; Hayakawa H
    Ann Am Thorac Soc; 2014 Jan; 11(1):23-9. PubMed ID: 24298907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A fast-growing cold skin abscess revealing disseminated Mycobacterium intracellulare infection in an HIV-infected patient.
    Mendes-Bastos P; Brás S; Carvalho R
    Int J STD AIDS; 2018 Jun; 29(7):720-722. PubMed ID: 29256823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Description of a new Mycobacterium intracellulare pattern of PCR restriction enzyme analysis of hsp65 gene.
    Caldas PC; Campos CE; Dos Reis LM; Ferreira NV; de Carvalho LD; da Silva MV; Medeiros RF; Montes FC; Ramos JP
    Diagn Microbiol Infect Dis; 2014 Jun; 79(2):240-1. PubMed ID: 24655570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.
    Shafran SD; Singer J; Zarowny DP; Phillips P; Salit I; Walmsley SL; Fong IW; Gill MJ; Rachlis AR; Lalonde RG; Fanning MM; Tsoukas CM
    N Engl J Med; 1996 Aug; 335(6):377-83. PubMed ID: 8676931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycobacterial infection identified with broad-range PCR amplification and suspension array identification.
    Carlos CA; Tang YW; Adler DJ; Kovarik CL
    J Cutan Pathol; 2012 Aug; 39(8):795-7. PubMed ID: 22764735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of clarithromycin-sensitive and clarithromycin-resistant Mycobacterium avium strains isolated from AIDS patients during therapy regimens including clarithromycin.
    Matsiota-Bernard P; Zinzendorf N; Onody C; Guenounou M
    J Infect; 2000 Jan; 40(1):49-54. PubMed ID: 10762111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "MAC" attack.
    Hong BK; Kumar C; Marottoli RA
    Am J Med; 2009 Dec; 122(12):1096-8. PubMed ID: 19958886
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease.
    Griffith DE; Brown-Elliott BA; Langsjoen B; Zhang Y; Pan X; Girard W; Nelson K; Caccitolo J; Alvarez J; Shepherd S; Wilson R; Graviss EA; Wallace RJ
    Am J Respir Crit Care Med; 2006 Oct; 174(8):928-34. PubMed ID: 16858014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective treatment for clarithromycin-resistant Mycobacterium avium complex lung disease.
    Adachi Y; Tsuyuguchi K; Kobayashi T; Kurahara Y; Yoshida S; Kagawa T; Hayashi S; Suzuki K
    J Infect Chemother; 2020 Jul; 26(7):676-680. PubMed ID: 32171660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease.
    Tanaka E; Kimoto T; Tsuyuguchi K; Watanabe I; Matsumoto H; Niimi A; Suzuki K; Murayama T; Amitani R; Kuze F
    Am J Respir Crit Care Med; 1999 Sep; 160(3):866-72. PubMed ID: 10471610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients.
    Wallace RJ; Brown BA; Griffith DE; Girard WM; Murphy DT
    Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1766-72. PubMed ID: 8665032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in drug susceptibility pattern between Mycobacterium avium and Mycobacterium intracellulare isolated in respiratory specimens.
    Cho EH; Huh HJ; Song DJ; Moon SM; Lee SH; Shin SY; Kim CK; Ki CS; Koh WJ; Lee NY
    J Infect Chemother; 2018 Apr; 24(4):315-318. PubMed ID: 29223615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates.
    Kobashi Y; Yoshida K; Miyashita N; Niki Y; Oka M
    J Infect Chemother; 2006 Aug; 12(4):195-202. PubMed ID: 16944258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cutaneous lesion in a patient with AIDS: an unusual presentation of infection due to Mycobacterium avium complex.
    Clark JA; Margolis DM
    Clin Infect Dis; 1993 Apr; 16(4):555-7. PubMed ID: 8513064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disseminated cutaneous mycobacterium avium complex in a person with AIDS.
    Endly DC; Ackerman LS
    Dermatol Online J; 2014 May; 20(5):22616. PubMed ID: 24852776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycobacterium avium complex develop resistance to synergistically active drug combinations during infection.
    Hoffner SE; Heurlin N; Petrini B; Svenson SB; Källenius G
    Eur Respir J; 1994 Feb; 7(2):247-50. PubMed ID: 8162976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic pitfall: Mycobacterium avium complex pulmonary infection and positive ANCA.
    Faruqi S; Kastelik JA; McGivern DV
    Eur J Intern Med; 2008 May; 19(3):216-8. PubMed ID: 18395168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary disease caused by Mycobacterium avium-intracellulare in HIV-negative patients: five-year follow-up of patients receiving standardised treatment.
    Int J Tuberc Lung Dis; 2002 Jul; 6(7):628-34. PubMed ID: 12102303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.